Patterns of care for stage III non–small cell lung cancer in Australia-Reference-Cited by-同舟云学术

Patterns of care for stage III non–small cell lung cancer in Australia

Published:2019-03-14 Issue:3 Volume:15 Page:93-100
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Parente Phillip¹,Chan Bryan A.²³,Hughes Brett G. M.³⁴,Jasas Kevin⁵,Joshi Rohit⁶,Kao Steven⁷,Hegi‐Johnson Fiona⁸,Hui Rina⁹¹⁰,McLaughlin‐Barrett Sara¹¹,Nordman Ina¹²,Stone Emily¹³

Affiliation:

1. Eastern Health Monash University Box Hill Victoria Australia

2. The Adem Crosby Cancer CentreSunshine Coast University Hospital Birtinya Queensland Australia

3. University of Queensland St Lucia Queensland Australia

4. The Royal Brisbane and Women's Hospital, Herston, The Prince Charles Hospital Chermside Queensland Australia

5. Sir Charles Gairdner Hospital Nedlands Western Australia Australia

6. Calvary Central Districts Hospital Elizabeth Vale, South Australia Australia

7. Chris O'Brien Lifehouse Camperdown NSW Australia

8. Peter MacCallum Cancer Centre Melbourne Victoria Australia

9. Westmead Hospital Westmead NSW Australia

10. University of Sydney Sydney NSW Australia

11. Monash Medical Centre Clayton Victoria Australia

12. Calvary Mater Newcastle Waratah NSW Australia

13. St Vincent's Hospital and Kinghorn Cancer Centre Darlinghurst NSW Australia

Funder

AstraZeneca Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13140

Reference68 articles.

1. Australian Institute of Health and Welfare.Lung Cancer in Australia.2011.

2. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

3. Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

4. Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer

5. Current Standards and Clinical Trials in Systemic Therapy for Stage III Lung Cancer: What Is New?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists;Oncology;2024

2. GRADE-ADOLOPMENT of clinical practice guidelines and creation of clinical pathways for the primary care management of chronic respiratory conditions in Pakistan;BMC Pulmonary Medicine;2023-04-17

3. Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice;BMC Cancer;2022-07-30

4. Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival;Translational Lung Cancer Research;2021-01

5. Influence of timeliness and receipt of first treatment on geographic variation in non‐small cell lung cancer mortality;International Journal of Cancer;2020-10-21